New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Friday, Nov 20, 2026
Export AZN’s income statement to Excel — free account
AstraZeneca PLC
AZNHealthcare Drug Manufacturers General
AstraZeneca PLC’s revenue for fiscal 2025 (year ended December 2025) was $58.7 billion, up 8.63% from fiscal 2024.
- Revenue
- +6.70%
- EPS
- +23.5%
- Free cash flow
- +1.99%
- Total debt
- +1.75%
Quarter to September 2026, against a year earlier
175.60
0.15
+0.09%
Follow AZN
Alert me
Where the cash went Fiscal 2025, year to Dec 31, 2025
Free cash flow of $11.8B covered $5.5B of dividends and buybacks. Cash rose by $269.0M. What is a cash flow statement?
- Free cash flow
- $11.8B 80.8% of operating cash flow
- Returned to shareholders
- $5.5B 46.3% of free cash flow
- Debt, net
- −$2.0B repaid
- Change in cash
- +$269.0M over the period
| Operating cash flow | 14.6 |
|---|---|
| Capital expenditures | −2.8 |
| Free cash flow | 11.8 |
| Acquisitions, net | −1.2 |
| Into investments, net | −0.1 |
| Dividends | −5.0 |
| Buybacks, net | −0.5 |
| Debt repaid, net | −2.0 |
| Other | −2.7 |
| Change in cash | 0.3 |
Free cash flow
| FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $4.1B | $3.6B | $2.6B | $3.0B | $4.8B | $6.0B | $9.8B | $10.3B | $11.9B | $14.6B |
| Capex | −$1.4B | −$1.2B | −$1.0B | −$942M | −$855M | −$1.1B | −$809M | −$1.2B | −$1.9B | −$2.8B |
| Free cash flow | $2.8B | $2.3B | $1.6B | $2.0B | $3.9B | $4.9B | $9.0B | $9.1B | $10.0B | $11.8B |
Figures in billions of dollars. Free cash flow is operating cash flow less capital expenditures. Investments are purchases less sales of securities; “Other” is what the named lines leave of the change in cash.
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Net Income |
12,402.00 | 8,691.00 | 6,899.00 | 2,501.00 | (265.00) | 3,916.00 | 1,548.00 | 1,993.00 | 2,227.00 | 3,552.00 |
Depreciation & Amortization |
5,733.00 | 6,688.00 | 5,387.00 | 5,480.00 | 6,530.00 | 3,149.00 | 3,762.00 | 3,753.00 | 3,036.00 | 2,357.00 |
Non Cash Items (Other) |
1,738.00 | 1,438.00 | 1,206.00 | 542.00 | 141.00 | (332.00) | (103.00) | (1,276.00) | (483.00) | (1,601.00) |
Accounts Receivable Change |
(1,728.00) | (1,624.00) | (1,425.00) | (1,349.00) | (961.00) | (739.00) | (898.00) | (523.00) | 83.00 | 1,610.00 |
Change in inventories |
(755.00) | (131.00) | (669.00) | 3,941.00 | 1,577.00 | (621.00) | (316.00) | (13.00) | (548.00) | (343.00) |
Accounts Payable Change |
1,346.00 | 862.00 | 2,394.00 | 1,165.00 | 1,405.00 | 1,721.00 | 868.00 | (103.00) | 415.00 | (341.00) |
Other operating activities |
(4,161.00) | (4,063.00) | (3,447.00) | (2,472.00) | (2,464.00) | (2,295.00) | (1,892.00) | (1,213.00) | (1,152.00) | (1,089.00) |
Operating Cash Flow |
14,575.00 | 11,861.00 | 10,345.00 | 9,808.00 | 5,963.00 | 4,799.00 | 2,969.00 | 2,618.00 | 3,578.00 | 4,145.00 |
Capital expenditures |
(2,797.00) | (1,869.00) | (1,229.00) | (809.00) | (1,078.00) | (855.00) | (942.00) | (1,031.00) | (1,243.00) | (1,364.00) |
Change in intangibles (net) |
(2,959.00) | (2,539.00) | (2,126.00) | (1,033.00) | (522.00) | (694.00) | 595.00 | 2,010.00 | 1,082.00 | 559.00 |
Net Aquisitions |
(1,230.00) | (3,779.00) | (1,015.00) | (48.00) | (9,263.00) | (822.00) | (709.00) | (349.00) | (1,450.00) | (2,564.00) |
Short Term Investments Change (Net) |
131.00 | 30.00 | 97.00 | (114.00) | 96.00 | 745.00 | 194.00 | 405.00 | (345.00) | (166.00) |
Long-Term Investments Change (Net) |
(239.00) | (163.00) | (184.00) | (29.00) | 601.00 | 1,262.00 | 5.00 | (78.00) | (26.00) | (227.00) |
Other investing activities |
286.00 | 340.00 | 393.00 | (927.00) | (892.00) | 79.00 | 200.00 | 6.00 | (346.00) | (207.00) |
Investing cash flow |
(6,808.00) | (7,980.00) | (4,064.00) | (2,960.00) | (11,058.00) | (285.00) | (657.00) | 963.00 | (2,328.00) | (3,969.00) |
Repayment/Issuance of Debt (Net) |
(2,022.00) | 1,493.00 | (1,233.00) | (1,441.00) | 7,654.00 | 1,440.00 | (1,702.00) | 1,473.00 | 560.00 | 2,172.00 |
Equity Repurchase (Common, Net) |
(481.00) | (43.00) | 33.00 | 29.00 | 29.00 | 30.00 | 3,525.00 | 34.00 | 43.00 | 47.00 |
Dividends Paid (Total) |
(4,971.00) | (4,629.00) | (4,481.00) | (4,364.00) | (3,856.00) | (3,572.00) | (3,592.00) | (3,484.00) | (3,519.00) | (3,561.00) |
Other financial activities |
(70.00) | (817.00) | (886.00) | (1,047.00) | (178.00) | (101.00) | 4.00 | (67.00) | (20.00) | 18.00 |
Financing cash flow |
(7,544.00) | (3,996.00) | (6,567.00) | (6,823.00) | 3,649.00 | (2,203.00) | (1,765.00) | (2,044.00) | (2,936.00) | (1,324.00) |
Exchange Rate Adjustment |
46.00 | (93.00) | (60.00) | (80.00) | (62.00) | 12.00 | 5.00 | (38.00) | (66.00) | 21.00 |
Change in Cash |
269.00 | (208.00) | (346.00) | (55.00) | (1,508.00) | 2,323.00 | 552.00 | 1,499.00 | (1,752.00) | (1,127.00) |
Beginning Cash |
5,429.00 | 5,637.00 | 5,983.00 | 6,038.00 | 7,546.00 | 5,223.00 | 4,671.00 | 3,172.00 | 4,924.00 | 6,051.00 |
Ending Cash |
5,698.00 | 5,429.00 | 5,637.00 | 5,983.00 | 6,038.00 | 7,546.00 | 5,223.00 | 4,671.00 | 3,172.00 | 4,924.00 |
Dividends Paid (Common) |
(4,971.00) | (4,629.00) | (4,481.00) | (4,364.00) | (3,856.00) | (3,572.00) | (3,592.00) | (3,484.00) | (3,519.00) | (3,561.00) |
Net Cash/Marketcap |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Assets Liabilities Change (Total) |
(1,137.00) | (893.00) | 300.00 | 3,757.00 | 2,021.00 | 361.00 | (346.00) | (639.00) | (50.00) | 926.00 |
Investments Change (Net) |
(108.00) | (133.00) | (87.00) | (143.00) | 697.00 | 2,007.00 | 199.00 | 327.00 | (371.00) | (393.00) |
Issuance/Purchase of Shares |
(481.00) | (43.00) | 33.00 | 29.00 | 29.00 | 30.00 | 3,525.00 | 34.00 | 43.00 | 47.00 |
| Other line items | ||||||||||
Revenue per Employee |
0.61 | 0.57 | 0.51 | 0.53 | 0.45 | 0.35 | 0.35 | 0.34 | 0.37 | 0.39 |
In millions of $ except per-share values · columns are period end dates · fundamentals updated Nov 18, 2026